• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC Biozorb; MARKER, RADIOGRAPHIC, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC Biozorb; MARKER, RADIOGRAPHIC, IMPLANTABLE Back to Search Results
Model Number F0202
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abscess (1690); Bacterial Infection (1735); Purulent Discharge (1812); Erythema (1840); Seroma (2069); Chills (2191); Breast Discomfort/Pain (4504); Swelling/ Edema (4577)
Date of Event 06/22/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.This report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
 
Event or Problem Description
Hologic has received correspondence arising from litigation.The litigation alleges that a patient received a biozorb implant post lumpectomy on (b)(6) 2022.It is alleged that the patient developed complications at the lumpectomy site, which include mastitis, abscess, redness, swelling, pain, chills and purulent drainage.Additionally, it is reported that the patient was hospitalized from (b)(6) 2025, with a diagnosis of mastitis and abscess and underwent an incision and drainage procedure.It is reported that "clips from the prior biozorb were removed during the i&d procedure." this report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Biozorb
Common Device Name
MARKER, RADIOGRAPHIC, IMPLANTABLE
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
dara smithers
600 technology drive
newark, DE 19702
MDR Report Key24604889
Report Number1222780-2026-00119
Device Sequence Number13348106
Product Code NEU
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K143484
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Type of Report Initial,Followup
Report Date (Section B) 09/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberF0202
Device Catalogue NumberF0202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/16/2026
Supplement Date Received by Manufacturer09/24/2026
Initial Report FDA Received Date03/16/2026
Supplement Report FDA Received Date09/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-